Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above
Clinical trial NCT00620815 · COMPLETED
Trial details
- NCT number
- NCT00620815
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-01-01
- Enrollment
- 601
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.